+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Ablynx  - logo

Ablynx NV, a biopharmaceutical company, develops Nanobodies that is a proprietary therapeutic protein based on single-domain antibody fragments for the treatment of various diseases. The company develops products in various therapeutic areas, such as inflammation, hematology, oncology, and respiratory diseases. The company was formerly known as MatchX and changed its name to Ablynx NV in June 2002. Ablynx NV was founded in 2001 and is headquartered in Ghent, Belgium.

Gene Therapy Collaboration and Licensing Deals 2016-2024 - Product Thumbnail Image

Gene Therapy Collaboration and Licensing Deals 2016-2024

  • Report
  • November 2024
  • 450 Pages
  • Global
From
From
Ion Channel Modulators - Global Strategic Business Report - Product Thumbnail Image

Ion Channel Modulators - Global Strategic Business Report

  • Report
  • November 2024
  • 172 Pages
  • Global
From
Respiratory Devices - Medical Devices Pipeline Assessment, 2020 - Product Thumbnail Image

Respiratory Devices - Medical Devices Pipeline Assessment, 2020

  • Report
  • February 2020
  • 628 Pages
  • Global
From
Biopharmaceuticals - A Global Market Overview - Product Thumbnail Image

Biopharmaceuticals - A Global Market Overview

  • Report
  • May 2019
  • 480 Pages
  • Global
From
Global Cancer Immunotherapy Market Analysis & Forecast to 2025 - Product Thumbnail Image

Global Cancer Immunotherapy Market Analysis & Forecast to 2025

  • Report
  • November 2020
  • 450 Pages
  • Global
From
Candidiasis Therapeutics Global Market Report 2024 - Product Thumbnail Image

Candidiasis Therapeutics Global Market Report 2024

  • Report
  • February 2024
  • 175 Pages
  • Global
From
TNF Alpha Inhibitors Global Market Report 2024 - Product Thumbnail Image

TNF Alpha Inhibitors Global Market Report 2024

  • Report
  • February 2024
  • 250 Pages
  • Global
From
Tumor Necrosis Factor Inhibitor Drugs Global Market Report 2024 - Product Thumbnail Image

Tumor Necrosis Factor Inhibitor Drugs Global Market Report 2024

  • Report
  • January 2024
  • 200 Pages
  • Global
From
From
Tumor Necrosis Factor Alpha (TNF-a) Agonist - Pipeline Insight, 2024 - Product Thumbnail Image

Tumor Necrosis Factor Alpha (TNF-a) Agonist - Pipeline Insight, 2024

  • Clinical Trials
  • January 2024
  • 60 Pages
  • Global
From
From
Ablynx NV - Strategic SWOT Analysis Review - Product Thumbnail Image

Ablynx NV - Strategic SWOT Analysis Review

  • SWOT Analysis
  • December 2021
  • 25 Pages
From
Loading Indicator